BDX - Becton Dickinson Short-Term Debt to Capital

bd.com - graphic logo of issuer BDX

Becton Dickinson & Co (BDX) generates revenue from global supplies of consumables and diagnostic systems. The short-term debt to equity trend helps assess the current debt load, with the 0.13 level serving as a critical benchmark. The business relies on laboratory automation and robotic medication dispensing. However, strict government regulatory oversight and the risk of product recalls could reduce overall profitability.

BDX - BD Short-Term Debt to Equity Ratio over the range 07/04/2022 - 10/31/2026

Analytical breakdowns for bd.com (BDX)

- stock quotes and analyst forecast:
Stock Price Becton, Dickinson and Company|BDX - Broker Consensus Forecast
- market capitalization statistics:
Market Capitalization Becton, Dickinson and Company|BDX - Company Buyout Price
- book capitalization information:
Book Value per Share Becton Dickinson|BDX - Company Net Assets|Market Capitalization to Book Value Ratio bd.com|BDX - Company Total Assets
- debt and liquidity details:
Debt to Equity Becton Dickinson & Co|BDX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Becton Dickinson|BDX - Aggregate Debt Obligations|Debts to Book Capitalization Becton, Dickinson and Company|BDX - Long-Term Debt Volume|Company Short-Term Debt Becton Dickinson|Quick Liquidity bd.com
- earnings and market ratios statistics:
BDX - Net Financial Result
Fundamental valuation:Becton, Dickinson and Company
Signature product of BD

The analyst assesses the credit risks of Becton Dickinson & Co (BDX) through the ratio of short-term liabilities to equity. The company's dominance in the medical consumables segment and stringent FDA barriers ensure a stable cash flow to service current loans. The company's short-term leverage history visualizes the share of "fast" loans within the financing structure relative to shareholder value. Low indicator values confirm financial autonomy, while moderate growth may suggest profitability optimization.

Main competitors

Short-Term Debt to Capital ISRG|Danaher Corporation Inc. - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital STE (STERIS plc)|Short-Term Debt to Capital Coefficient westpharma.com (WST)|Baxter - Short-Term Debt to Capital|Masimo Corp (MASI) - Short-Term Debt to Equity Ratio|STVN: Short-Term Debt to Capital|Teleflex Corp (TFX) - Short-Term Debt to Capital|Short-Term Debt to Equity Merit Medical Systems|Short-Term Debt to Equity NVST|Short-Term Debt to Equity Ratio ICUI (ICU Medical)|XRAY (Dentsply Sirona Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital LMAT (LeMaitre)|Short-Term Debt to Capital Coefficient AtriCure Medical (ATRC)|STAA - Short-Term Debt to Equity|NAGE (ChromaDex Corp) - Short-Term Debt to Capital Ratio|ZimVie (ZIMV) - Short-Term Debt to Equity|ANGO - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio CERS|TKNO (Teknova Inc) - Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Monogram Technologies (MGRM)|STSS (sharpstechnology.com) - Ratio of Short-Term Indebtedness to Capital|InfuSystem Holdings, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Utah Medical Products Inc. UTMD|KRMD - Short-Term Debt to Equity|Nyxoah S.A (NYXH) - Short-Term Debt to Equity Ratio|MBOT: Short-Term Debt to Capital|Current Liabilities to Capital pro-dex.com (PDEX)|Short-Term Debt to Equity Zentek|Short-Term Debt to Capital Ratio ELUT (Elutia Inc)|Short-Term Debt to Equity Ratio MLSS (Milestone Scientific Corp)|Short-Term Loans to Capital Ratio NXGL|Short-Term Debt to Equity Retractable Technologies, Inc. RVP|Short-Term Debt to Capital Coefficient Harvard Bioscience Inc. (HBIO)|Femasys - Short-Term Debt to Capital|MHUA: Short-Term Debt to Equity|POAI: Short-Term Debt to Capital|Current Liabilities to Capital Callan JMB (CJMB)|ATRI (Atrion Corporation) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio neurometrix.com (NURO)